Harmony’s sleep disorder drug Wakix gets US label extensionHarmony Biosciences has scored an expanded use for its Wakix narcolepsy drug to include cataplexy – a symptom Share XHarmony’s sleep disorder drug Wakix gets US label extensionhttps://pharmaphorum.com/news/harmonys-narcolepsy-drug-gets-extended-cataplexy/
FDA approves Jazz Pharmaceuticals’ narcolepsy therapyThe FDA has approved Jazz Pharmaceuticals’ sleep disorder drug Xywav, to treat daytime sleepiness in patients with narcolepsy, Share XFDA approves Jazz Pharmaceuticals’ narcolepsy therapyhttps://pharmaphorum.com/news/fda-approves-jazz-pharmaceuticals-narcolepsy-therapy/
